AGEN EURO - AN OVERVIEW

Emily Bodnar’s rating relies over the anticipation of significant milestones for Agenus in the coming yr, notably the opportunity submitting of the Biologics License Application (BLA) for their lead drug candidate, botensilimab (bot). Agenus has dosed above 900 sufferers with bot throughout several good tumors, demonstrating a determination to su